CAS: 19356-17-3; (R,Z)-3-(2-((1R,3As,7Ar,E)-1-((R)-6-Hydroxy-6-Methylheptan-2-yl)-7A-Methyloctahydro-4H-Inden-4-Ylidene)Ethylidene)-4-Methylenecyclohexan-1-Ol

该化合物是肝脏中通过维生素D3(胆碱酯酶)的氢氧化物生成的先激酮,是维生素D的主要循环代谢物,是评估临床环境中维生素D状况的重要生物标志.Calcifediol比当地维生素D的生物利用率高,因为它绕过肝水氧化物,能够更有效地转换为活性形式,卡西狄醇(1,25-二羟基羟基维他明D3),这种特性特别有助于治疗肝功能受损病人的维生素D缺乏症,其延长的半衰期允许较少的剂量,确保稳定的血清水平.Calcifediol因其可靠的药用基因特征,在治疗和诊断应用中被广泛使用.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号61585-29-3 25-Hydroxyprovi... | CAS号104973-29-7 6(S),19-(N,N'-p... | CAS号104875-13-0 (2S,14S)-14-((E... | CAS号87417-16-1 (3-methyl-3-((t... | CAS号87417-00-3 6(S),19-(N,N'-p... | CAS号104973-32-2 6(S),19-(N,N'-p... | CAS号50-14-6 维生素D2 | CAS号87680-65-7 维生素D2 SO2加合物 | CAS号140710-90-3 3-O-叔丁基二甲基甲硅烷基骨化二醇 | CAS号32222-06-3 骨化三醇

合成工艺路线路线简述

  • 合成目标产物 Calcifediol 主要起始原料 (S,E)-3-((E)-2-((1R,3As,7Ar)-1-((R)-6-Hydroxy-6-Methylheptan-2-yl)-7A-Methylhexahydro-1H-Inden-4(2H)-Ylidene)Ethylidene)-4-Methylenecyclohexanol
  • (文献来源)合成步骤主要原料 (S,E)-3-((E)-2-((1R,3As,7Ar)-1-((R)-6-Hydroxy-6-Methylheptan-2-yl)-7A-Methylhexahydro-1H-Inden-4(2H)-Ylidene)Ethylidene)-4-Methylenecyclohexanol
维生素 D3置于双氧水体系中,用 Aq. Phosphate Buffer 用作溶剂,化学反应 1.0H,以100%的收率获得骨化二醇
参考文献:灰霉菌过氧化物酶生产25-羟基维生素d的区域选择性羟化反应
标题:灰霉菌过氧化物酶生产25-羟基维生素d的区域选择性羟化反应
摘要:维生素d 3(胆钙化固醇)和维生素d 2(麦角钙化固醇)的单羟基化代谢物(通常称为25-羟基钙化固醇)比维生素d (钙化固醇)更适合于多种疾病和其他应用.这项工作描述了从容易获得的胆钙化醇和麦角钙化醇开始制备25-羟基钙化醇的新型生物技术方法.该方法通过使用灰霉菌真菌的过氧化物酶(来自测序基因组的基因模型cc1G_08427T0 )在温和且环境友好的条件下使这些化合物(在c-25位置)的区域选择性(100%)羟基化,从而催化单氧合反应. H 2 O 2作为唯一的共底物(过氧化酶).胆钙化固醇和麦角钙化固醇的羟基化是真正的过氧化,如通过将h 2 18 O 2中的18 O掺入产品中所证明的.过氧合酶具有与其重组性质相关的其他优势,可在工业宿主中进行酶工程和低成本过表达.因此,过氧合酶是生产维生素d活性代谢产物的有前途的生物催化剂.
Doi:10.1002/cctc.201402795

海关参考信息

专利信息


专利号:US-2022267266-A1
优先权日:2019-07-09
标 题 :Improved, cost effective process for synthesis of vitamin d3 and its analogue calcifediol from ergosterol
发明人:DATLA ANUPAMA; NAGRE PRASHANT; TAMORE JAGDISH; PRABHU MANOJKUMAR SADANAND; KADAM SACHIN VASANT
权利人:FERMENTA BIOTECH LTD
摘要:Disclosed herein is an improved and efficient process for synthesis of vitamin D3 and its analogue Calcifediol from Ergosterol. Particularly, the present invention discloses the synthesis of key intermediate 3β-tert-Butyldimethylsilyloxy-22-hydroxy-23,24-bisnorchola-5,7-diene (5), and novel intermediate β-tert-Butyldimethylsilyloxy-22-iodo-23,24-bisnorchola-5,7-diene (9) by a simple and cost effective process. The industrially viable processes for preparation of said intermediate(s) results in providing provitamins with various side chains and the desired products in high yield.

专利号:US-4174345-A
优先权日:1978-08-01
标题:Synthesis of steroids
发明人:KAISER EMIL T
权利人:KAISER EMIL T
摘要:In the synthesis of sterols wherein methoxyethoxymethyl groups in an ether linkage are attached to the nucleus of the sterol to protect the sterol nucleus during other steps of the synthesis and the sterols are thereafter treated to remove the methoxyethoxymethyl groups and set free the hydroxyl groups, the improvement in which the sterols being treated with zinc bromide are held in a methylene chloride solution containing a small amount of an aliphatic alcohol having from 1 to 6 carbon atoms.

专利号:US-4226770-A
优先权日:1978-02-10
标题:Synthesis of steroids
发明人:KAISER EMIL T
权利人:KAISER EMIL T
摘要:The synthesis of 1α,25-dihydroxycholesterol, 1α,25-dihydroxy-7-dehydrocholesterol and 1α,25-dihydroxycholecalciferol and other sterol derivatives from bile acids. Also the synthesis of 3,6-diketo steroids useful in the production of 1α,25-dihydroxycholesterol and other sterols which are biologically active or can be converted to biologically active sterols. The invention involves the sterols so produced and the processes by which they are prepared.

专利号:US-4163744-A
优先权日:1978-02-10
标 题:Synthesis of steroids
发明人:KAISER EMIL T
权利人:KAISER EMIL T
摘要:The synthesis of 1α,25-dihydroxycholesterol, 1α,25-dihydroxy-7-dehydrocholesterol and 1α,25-dihydroxycholecalciferol and other sterol derivatives from bile acids. Also the synthesis of 3,6-diketo steroids useful in the production of 1α,25-dihydroxycholesterol and other sterols which are biologically active or can be converted to biologically active sterols. The invention involves the sterols so produced and the processes by which they are prepared.

专利号:US-9994508-B2
优先权日:2012-12-11
标 题:Versatile and functionalised intermediates for the synthesis of vitamin D and novel vitamin D derivatives
发明人:LOPEZ PEREZ BORJA; SIGUEIRO PONTE RITA; MAESTRO SAAVEDRA MIGUEL A; MOURINO MOSQUERA ANTONIO
权利人:ENDOTHERM GMBH
摘要:Novel intermediates for the complete synthesis of vitamin D are provided that allow a great versatility of functional groups in the final vitamin derivatives. Vitamin derivatives that are epimeric in position 3 and vitamin derivatives with a wide range of functionalities in position 18, including compounds with isotopic labelling are provided.

专利号:US-4217279-A
优先权日:1978-12-18
标 题 :Synthesis of steroids
发明人:KAISER EMIL T
权利人:KAISER EMIL T
摘要:The synthesis of 25-hydroxycholesterol and 1α,25-dihydroxycholesterol in which the sterol nucleus of an ester of hyodeoxycholic acid is stabilized by protection of the 3 and 6α-hydroxyl groups with alkyl groups, alkyl ether groups, preferably with the 3β-methoxyethoxymethyl group or with the heterocyclic 2-tetrahydropyran group, then extending the chain from the carbon at the 24-position to a cyanide group at the 25-position and then subjecting the sterol so formed to a series of reactions by which it is transformed into 1α,25-dihydroxycholesterol or by a modified series of reactions to 25-hydroxycholesterol.
上海诺吉化工科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: https://www.norkypharm.com
电话: 021-021-61075308 15216782696👤
📞上海诺吉化工科技有限公司 ⚠️参考联系方式

销售电话:021-021-61075308 15216782696
邮箱:sales@norkysh.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
成都曼思特生物科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.cdmust.com
电话: 028-87384368👤
📞成都曼思特生物科技有限公司 ⚠️参考联系方式

销售电话:028-87384368
邮箱:cdmust@163.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
山东静远化学有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.joyochem.com
电话: 0531-82687558,82687998👤
📞山东静远化学有限公司 ⚠️参考联系方式

销售电话:0531-82687558,82687998
邮箱:jy@jychem.cc
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献


1: Gümüş P, Öztürk VÖ, Bozkurt E, Emingil G. Evaluation of the gingival inflammation in pregnancy and postpartum via 25-hydroxy-vitamin D3, prostaglandin E2 and TNF-α levels in saliva. Arch Oral Biol. 2016 Mar;63:1-6. doi: 10.1016/j.archoralbio.2015.11.018. Epub 2015 Nov 25. doi: 10.1371/journal.ppat.1005007. eCollection 2015 Jul.
3: Narayanaswamy R, Iyer V, Khare P, Bodziak ML, Badgett D, Zivadinov R, Weinstock-Guttman B, Rideout TC, Ramanathan M, Browne RW. Simultaneous determination of oxysterols, cholesterol and 25-hydroxy-vitamin D3 in human plasma by LC-UV-MS. PLoS One. 2015 Apr 13;10(4):e0123771. doi: 10.1371/journal.pone.0123771. eCollection 2015.
4: Burild A, Frandsen HL, Poulsen M, Jakobsen J. Tissue content of vitamin D3 and 25-hydroxy vitamin D3 in minipigs after cutaneous synthesis, supplementation and deprivation of vitamin D3. Steroids. 2015 Jun;98:72-9. doi: 10.1016/j.steroids.2015.02.017. Epub 2015 Feb 26. doi: 10.1007/s00774-014-0585-7. Epub 2014 Apr 22.

合成参考文献


参考文献:10.1016/j.jsbmb.2010.01.011
摘要:Menegaz D, Barrientos-Duran A, Kline A, Silva FRMB, Norman AW, Mizwicki MT, Zanello LP. 1α,25(OH)2-Vitamin D3 stimulation of secretion via chloride channel activation in Sertoli cells. The Journal of Steroid Biochemistry and Molecular Biology. 2010 Apr;119(3-5):127–34. doi: 10.1016/j.jsbmb.2010.01.011.
摘要:Ma XL, Zhen YF. [Serum levels of 25-(OH)D(3) and total IgE in children with asthma]. Zhongguo Dang Dai Er Ke Za Zhi. 2011 Jul;13(7):551–3.
参考文献:10.1530/eje-11-0545
摘要:Pacifico L, Anania C, Osborn JF, Ferraro F, Bonci E, Olivero E, Chiesa C. Low 25(OH)D3 levels are associated with total adiposity, metabolic syndrome, and hypertension in Caucasian children and adolescents. Eur J Endocrinol. 2011 Oct;165(4):603–11. doi: 10.1530/eje-11-0545.
参考文献:10.3382/ps.2011-01379
摘要:Käppeli S, Gebhardt-Henrich SG, Fröhlich E, Pfulg A, Schäublin H, Stoffel MH. Effects of housing, perches, genetics, and 25-hydroxycholecalciferol on keel bone deformities in laying hens. Poult Sci. 2011 Aug;90(8):1637–44. doi: 10.3382/ps.2011-01379.
参考文献:10.1159/000325459
摘要:Cianciolo G, La Manna G, Cappuccilli ML, Lanci N, Della Bella E, Cuna V, Dormi A, Todeschini P, Donati G, Alviano F, Costa R, Bagnara GP, Stefoni S. VDR expression on circulating endothelial progenitor cells in dialysis patients is modulated by 25(OH)D serum levels and calcitriol therapy. Blood Purif. 2011;32(3):161–73. doi: 10.1159/000325459.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知